INIS
patients
100%
lungs
82%
genes
59%
diseases
57%
cancer
41%
sex
30%
colombia
27%
adenocarcinomas
27%
tissues
26%
transcription factors
21%
fishes
20%
karyotype
19%
tumors
18%
females
16%
genetics
16%
hospitals
16%
in-situ hybridization
16%
fluorescence
16%
correlations
15%
enrichment
15%
males
15%
rna
13%
ducts
13%
blood
13%
defects
13%
sarcomas
13%
barriers
13%
lymphomas
13%
kinases
13%
biological markers
13%
surges
13%
osteoblasts
13%
mortality
13%
oncogenes
13%
interstitials
13%
saturation
12%
distance
11%
levels
11%
anemias
11%
phenotype
10%
etiology
9%
promoters
7%
variations
7%
kidneys
7%
gonads
6%
pathology
6%
mosaicism
6%
congenital diseases
6%
information
5%
chromosomes
5%
abnormalities (chromosomal)
5%
limbs
5%
malformations
5%
hybridization
5%
pcr
5%
probes
5%
amplification
5%
Biochemistry, Genetics and Molecular Biology
Transcription Factors
37%
Genetics
35%
Bioinformatics
32%
SOX9
32%
Epigenetics
29%
Gene Expression Profiling
29%
Cytogenetics
29%
Karyotype
27%
Epigenetic Mechanism
23%
Gonad Development
22%
Multiplex Ligation-Dependent Probe Amplification
22%
Promoter Region
21%
Fluorescence in Situ Hybridization
21%
Transcription Factor RUNX
20%
Copy-Number Variation
18%
SRY Gene
18%
Gene Expression
17%
Chromosomal Abnormalities
16%
Gene Dosage
16%
Transcription
16%
Tumor Gene
15%
Gene Mutation
14%
Sex Differentiation
13%
Long Noncoding RNA
13%
Periostin
13%
Anaplastic Lymphoma Kinase
13%
Karyotype 47,XXY
13%
RUNX2
13%
Mosaicism
13%
Oncogene
13%
Tumor Suppressor Protein
13%
Gene Regulatory Network
13%
Ewing Sarcoma
13%
Osteoblast
13%
Transgenic Mouse
13%
C9orf72
13%
Astrocyte
13%
Real-Time Polymerase Chain Reaction
11%
Genetic Determinism
10%
Embryogenesis
9%
SOX3
9%
Karyotyping
9%
Transcriptomics
8%
Klinefelter Syndrome
8%
Karyotype 46,XY
8%
Sex Chromosome
7%
Teratoma
6%
Downregulation
6%
Testis Development
6%
Tracheoesophageal Fistula
6%
Hub Genes
6%
Shear Stress
6%
Cell Function
6%
Candidate Gene
6%
WT1
6%
Array Comparative Genomic Hybridization
6%
Decision Support System
6%
Comorbidity
6%
Transcriptome
6%
Mouse Model
6%
Regulatory Network
5%
Turner Syndrome
5%
Fusion Gene
5%
FLI1
5%
Protein Biosynthesis
5%
Keyphrases
Müllerian Structures
13%
Compound Heterozygous mutation
13%
Persistent Müllerian Duct Syndrome
13%
Runt-related Transcription Factor 2 (Runx2)
13%
Master Genes
13%
H3K4me3
13%
COMPASS Complex
13%
Osteoblast
13%
Barriers to Access
13%
Oncogene
13%
Anaplastic Lymphoma Kinase
13%
Anaplastic Lymphoma Kinase Gene
13%
Lung Adenocarcinoma
13%
Ewing Sarcoma
13%
Characteristic number
13%
VACTERL Association
13%
Fanconi Anemia
13%
RUNX Family
13%
Oncogenic Process
13%
Tumor Suppressor
13%
Genetic Characterization
13%
Patient Cohort
13%
Cytogenetic Characterization
13%
Lung-other
13%
BAC Transgenic Mice
13%
H3K9me3
13%
Transcriptional Targets
13%
SRY Gene
13%
Chromosomal Genes
13%
Gene Finding
13%
Lung Cancer Biomarkers
13%
47,XXY
13%
Gonadal Dysgenesis
13%
Klinefelter
13%
XYY Syndrome
13%
Barriers in Access
9%
Distance Walked
9%
Klinefelter Syndrome
8%
Uterus
6%
Anti-Müllerian Hormone
6%
Bilateral Cryptorchidism
6%
Adult Male
6%
Phenotypic Male
6%
Incidental
6%
Fallopian Tube
6%
AMHR2 Gene
6%
Abdominal Mass
6%
Cryptorchidism
6%
Regulatory Ability
6%
Oncogenic Potential
6%
Chromosome 2
6%
Pathology Department
6%
ALK Inhibitor
6%
Lung Cancer Patients
6%
2 Regions
6%
Anaplastic Lymphoma Kinase Rearrangement
6%
Short-arm
6%
IHC Assay
6%
NSCLS
6%
Paraffin-embedded Samples
6%
FISH Assay
6%
Limb Defects
6%
Choanal Atresia
6%
Master Regulator
6%
Dual Function
6%
Diagnostic Interventions
6%
Oncogenic Signaling
6%
Whole Family
6%
Developmental Programming
6%
Biological Characteristics
6%
Runt-related Transcription Factor
6%
Molecular Study
6%
Transcription Factor Family
6%
Vertebral Abnormalities
6%
Gonadal Differentiation
6%
Fusion Gene
5%
EWS-FLI1
5%
Splicing Process
5%
Transcriptional Network
5%
Dysregulated
5%
Chromocenter
5%